| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| JANUS HENDERSON GROUP PLC | 10% | $27,835,737 | 14,885,421 | JANUS HENDERSON GROUP PLC | 28 Nov 2025 | |||
| PERCEPTIVE ADVISORS LLC | 10% | $7,100,950 | 12,243,018 | Perceptive Advisors LLC | 02 Oct 2025 | |||
| Deep Track Capital, LP | 10% | $5,807,516 | 10,012,958 | Deep Track Capital, LP | 01 Oct 2025 | |||
| RA CAPITAL MANAGEMENT, L.P. | 9.9% | $5,762,741 | 9,935,761 | RA Capital Management, L.P. | 02 Oct 2025 | |||
| Commodore Capital LP | 9.9% | $5,620,586 | 9,690,665 | Commodore Capital LP | 01 Oct 2025 | |||
| Squadron Capital Management LLC | 8.5% | $4,785,000 | 8,250,000 | Squadron Capital Management LLC | 01 Oct 2025 | |||
| Point72 Asset Management, L.P. | 6.2% | $4,399,654 | 7,585,611 | Point72 Asset Management, L.P. | 06 Oct 2025 | |||
| ARMISTICE CAPITAL, LLC | 10% | 0% | $339,772 | +$134,272 | 471,906 | +65% | Armistice Capital, LLC | 31 Mar 2025 |
As of 30 Sep 2025, 12 institutional investors reported holding 119,592 shares of PALISADE BIO, INC. - Common Stock (PALI). This represents 0.08% of the company’s total 149,003,213 outstanding shares.
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q3 | 119,592 | $102,817 | +$30,260 | $0.86 | 12 |
| 2025 Q2 | 84,610 | $57,544 | -$119,034 | $0.68 | 11 |
| 2025 Q1 | 260,593 | $176,598 | -$26,885 | $0.68 | 11 |
| 2024 Q4 | 199,223 | $328,718 | +$210,668 | $1.65 | 9 |
| 2024 Q3 | 62,098 | $220,448 | +$113,672 | $3.55 | 8 |
| 2024 Q2 | 30,078 | $135,352 | +$135,352 | $4.50 | 7 |